Brokerages Set DRI Healthcare Trust (TSE:DHT.UN) Price Target at C$17.94

Shares of DRI Healthcare Trust (TSE:DHT.UN) have been given an average rating of “Moderate Buy” by the six analysts that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is C$17.94.

A number of brokerages have commented on DHT.UN. CIBC decreased their price objective on shares of DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating on the stock in a report on Thursday, December 12th. Scotiabank raised their price target on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Finally, Raymond James reduced their price objective on DRI Healthcare Trust from C$23.00 to C$22.00 in a report on Wednesday, November 13th.

DRI Healthcare Trust Trading Down 1.6 %

DHT.UN stock opened at C$11.82 on Monday. DRI Healthcare Trust has a 1-year low of C$10.39 and a 1-year high of C$17.43. The business’s 50 day moving average is C$12.96 and its 200-day moving average is C$13.03.

DRI Healthcare Trust Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, October 18th were issued a dividend of $0.085 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.34 dividend on an annualized basis and a dividend yield of 2.88%. DRI Healthcare Trust’s payout ratio is presently -920.00%.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.